A detailed history of Canada Pension Plan Investment Board transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 294,336 shares of EW stock, worth $19.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
294,336
Previous 327,112 10.02%
Holding current value
$19.4 Million
Previous $31.3 Million 13.02%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$84.3 - $94.31 $2.76 Million - $3.09 Million
-32,776 Reduced 10.02%
294,336 $27.2 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $22.4 Million - $29.6 Million
-309,251 Reduced 48.6%
327,112 $31.3 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $754,281 - $950,460
12,223 Added 1.96%
636,363 $48.5 Million
Q3 2023

Nov 09, 2023

SELL
$69.28 - $93.38 $1.57 Million - $2.12 Million
-22,700 Reduced 3.51%
624,140 $43.2 Million
Q2 2023

Aug 09, 2023

SELL
$81.41 - $94.33 $651,280 - $754,640
-8,000 Reduced 1.22%
646,840 $61 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $4.65 Million - $5.3 Million
-62,678 Reduced 8.74%
654,840 $54.2 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $2.26 Million - $2.89 Million
33,020 Added 4.82%
717,518 $53.5 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $13.5 Million - $17.6 Million
163,900 Added 31.48%
684,498 $56.6 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $2.42 Million - $3.59 Million
-28,000 Reduced 5.1%
520,598 $49.5 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $47.4 Million - $59.7 Million
-465,011 Reduced 45.88%
548,598 $64.6 Million
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $41.3 Million - $50.7 Million
-388,200 Reduced 27.69%
1,013,609 $131 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $14.3 Million - $17.1 Million
139,409 Added 11.04%
1,401,809 $159 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $31.5 Million - $39.3 Million
375,575 Added 42.35%
1,262,400 $131 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $25.6 Million - $29.5 Million
325,691 Added 58.04%
886,825 $74.2 Million
Q4 2020

Feb 17, 2021

SELL
$71.69 - $91.23 $11.3 Million - $14.3 Million
-157,291 Reduced 21.89%
561,134 $51.2 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $5.03 Million - $6.55 Million
-74,873 Reduced 9.44%
718,425 $57.3 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $40.6 Million - $54.3 Million
705,137 Added 799.83%
793,298 $54.8 Million
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $8.36 Million - $12.9 Million
-159,510 Reduced 64.4%
88,161 $16.6 Million
Q4 2019

Feb 14, 2020

SELL
$71.7 - $82.09 $280,562 - $321,218
-3,913 Reduced 1.56%
247,671 $57.8 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $4.35 Million - $5.33 Million
70,656 Added 39.05%
251,584 $55.3 Million
Q2 2019

Aug 12, 2019

BUY
$55.74 - $64.41 $91,413 - $105,632
1,640 Added 0.91%
180,928 $33.4 Million
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $4.22 Million - $5.64 Million
88,101 Added 96.62%
179,288 $34.3 Million
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $2.32 Million - $2.85 Million
-50,023 Reduced 35.42%
91,187 $14 Million
Q3 2018

Nov 09, 2018

BUY
$45.7 - $58.03 $4.47 Million - $5.68 Million
97,900 Added 226.04%
141,210 $24.6 Million
Q2 2018

Aug 07, 2018

SELL
$42.45 - $51.3 $3.87 Million - $4.68 Million
-91,235 Reduced 67.81%
43,310 $6.31 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $2.53 Million - $3.23 Million
68,100 Added 102.49%
134,545 $18.8 Million
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $2.04 Million - $2.37 Million
60,252 Added 972.9%
66,445 $7.49 Million
Q3 2017

Oct 30, 2017

BUY
$36.29 - $38.83 $198,506 - $212,400
5,470 Added 756.57%
6,193 $677,000
Q2 2017

Jan 31, 2018

SELL
N/A
-92,441 Reduced 99.22%
723 $85,000
Q1 2017

Jan 31, 2018

BUY
N/A
93,164
93,164 $8.76 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.